首页> 外文期刊>Japanese Journal of Pharmacology >Calcium Polycarbophil, a Water Absorbing Polymer, Increases Bowel Movement and Prevents Sennoside-Induced Diarrhea in Dogs
【24h】

Calcium Polycarbophil, a Water Absorbing Polymer, Increases Bowel Movement and Prevents Sennoside-Induced Diarrhea in Dogs

机译:聚卡波非钙,一种吸水聚合物,可增加肠蠕动并预防狗的皂苷引起的腹泻

获取原文
           

摘要

References(32) Cited-By(6) The effects of calcium polycarbophil(CP), a water−absorbing polymer, on bowel movement were examined in comparison with known laxatives and anti−diarrheal agents in dogs, a species that resembles humans for stool output.CP increased stool frequency, fecal water content and fecal weight in a dose−dependent manner, but did not induce diarrhea.Sennoside and carboxymethylcellulose sodium(CMC−Na)increased fecal water content and induced diarrhea at lower doses than that which enhanced stool frequency.Trimebutine decreased stool frequency, fecal weight and fecal water content, resulting in inhibition rather than stimulation of defecation.In sennoside−induced diarrhea, loperamide and CP improved stool consistency and this was accompanied by reduced fecal moisture and frequency of diarrhea.In contrast, CMC−Na aggravated stool consistency with increased fecal water content and frequency of diarrhea, and trimebutine had little noticeable effect apart from reducing fecal weight.Our results show that CP has both laxative and anti−diarrheal effects in dogs and differed from conventional laxatives and anti−diarrheal agents.CP may be a suitable agent for treatment of idiopathic constipation, secretory diarrhea and irritable bowel syndrome with alternating constipation and diarrhea and with either predominating in terms of less side effects such as diarrhea or constipation.
机译:参考文献(32)被引用的文献(6)与已知的通便剂和抗腹泻剂相比,研究了吸水聚合物聚卡波非钙(CP)对肠蠕动的影响,该狗类似于人类的粪便。 CP以剂量依赖的方式增加粪便频率,粪便含水量和粪便重量,但不会引起腹泻。山茱side苷和羧甲基纤维素钠(CMC-Na)的粪便含水量增加并以比增加粪便剂量低的剂量引起腹泻。曲美布汀降低粪便频率,粪便重量和粪便水含量,从而抑制排便而不是刺激排便;在山参皂苷引起的腹泻中,洛哌丁胺和CP改善了粪便的稠度,同时粪便水分和腹泻频率降低。 ,CMC-Na加重了粪便的浓度,增加了粪便中的水分含量和腹泻频率,曲美布汀除了减少粪便外几乎没有明显的作用体重。腹泻,并以较少的副作用(例如腹泻或便秘)为主。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号